You are on page 1of 1

Stamets Live Mycelial Extracts of Mushroom Species and Blends Having Activity Against Viruses as Noted by Selectivity Index

(SI) Values Provided by the USAMRIID / NIH / USAID BioShield BioDefense Program
s
Compounds that have an SI index value of 2 or more are considered active

ll A value of 10 or greater is considered very active

VIRUSES
Ganoderma resinaceum
Red Reishi

MUSHROOM EXTRACTS
Fomitopsis officinalis
Agaikon

Piptoporus betulinus
Birch Polypore

Influenza Viruses Flu A H1N1 H3N2 H5N1 Flu B Orthopox Viruses Cowpox Vaccinia Smallpox Pichinde Punta Toro Tacaribe West Nile Yellow Fever

s s s s ll ll
(research results pending)

s s s

s s

s s s s s

Mycelial extracts diluted 100:1 to 1000:1. Patents pending: U.S. Patent Application Serial No. 11/029,86; 11/031,699 International Patent PCT/US05/00266
The above research results are a compendium of tests over the past 3 years, using human cell lines in vitro. Mammalian studies are planned. As such, conclusions as to antiviral activity must be confirmed through continuing research trials using animals and humans. Until then, these results are not intended to diagnose, treat, cure, or prevent viral infections.

You might also like